Triple-negative breast cancer cells overexpress MYC and MCL1, which together maintain chemotherapy-resistant cancer stem cells by enhancing mitochondrial OXPHOS, increasing ROS production, and inducing HIF1α expression [133]. Here, MYC is linked to cancer.